Arabella Buchmann
Graz, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Serum Neurofilament Light Chain in Patients with Dominant Optic Atrophy - A Case-Control Study.
Journal: Neuro-ophthalmology (Aeolus Press)
Published: April 07, 2025
Impact of level 2 hypoglycaemia on neuroaxonal damage biomarker in individuals with type 2 diabetes: A stepwise hypoglycaemic clamp study.
Journal: Diabetes, obesity & metabolism
Published: January 30, 2025
Serum Neurofilament Light and Clinical Biomarkers for Disease Staging in Huntington's Disease.
Journal: Movement disorders clinical practice
Published: August 21, 2023
Elevated serum neurofilament light chain protein in patients with essential tremor.
Journal: European journal of neurology
Published: August 02, 2023
Serum neurofilament light as a potential marker of illness duration in bipolar disorder.
Journal: Journal of affective disorders
Published: July 20, 2023
Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis.
Journal: JAMA neurology
Published: February 06, 2023
Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting.
Journal: International journal of molecular sciences
Published: December 19, 2022
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis.
Journal: European journal of neurology
Published: November 01, 2022
Redox State of Human Serum Albumin in Multiple Sclerosis: A Pilot Study.
Journal: International journal of molecular sciences
Published: October 18, 2022
Evidence for an Intrathecal Immunoglobulin Synthesis by Kappa Free Light Chains in Neurological Patients with an Isolated Band in Isoelectric Focusing.
Journal: Biomedicines
Published: June 25, 2022
Last Updated: 09/26/2026